Ranking Profile - Crinetics Pharmaceuticals Inc

Introduction

Crinetics Pharmaceuticals Inc (Crinetics Pharmaceuticals) is a clinical stage pharmaceutical company. It develops novel therapeutics targeting peptide hormone receptors for the treatment of rare endocrine disorders and endocrine-related tumors. The company’s product pipeline includes paltusotine (Oral SST2 agonist) to treat acromegaly; CRN04777 (SST5 agonist) against congenital hyperinsulinism; and CRN04894 (ACTH agonist) for treatment of cushing's disease and congenital adrenal hyperplasia. Crinetics Pharmaceuticals provides somatostatin agonists for the treatment of pancreatic neuroendocrine tumors, carcinoid tumors, GH secreting adenomas, diabetic retinopathy, graves ophthalmopathy, chronic pain, epilepsy, and dementia. The company is also developing other drug programs to treat polycystic kidney disorders, hyperparathyroidism, and obesity. Crinetics Pharmaceuticals is headquartered in San Diego, California, the US.